2026 Global: Intracranial Pressure Monitoring Devices Market-Competitive Review (2032) report
Description
The 2026 Global: Intracranial Pressure Monitoring Devices Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Medtronic plc, headquartered in Dublin, Ireland, is a global leader in neuromonitoring and intracranial pressure monitoring devices, integrating ICP sensors with its broad portfolio of neurocritical care products. Integra LifeSciences Corp, headquartered in Plainsboro, New Jersey, United States, markets Codman ICP monitors and related neurocritical care hardware, reflecting its historical emphasis on neurosurgical instrumentation. Smiths Medical, based in London, United Kingdom, supplies ICP monitoring accessories and external drainage systems used in critical care settings, aligning with its broad portfolio of acute care devices. LivaNova PLC, headquartered in London, United Kingdom, operates in the neuromonitoring space with ICP sensors and associated neurodiagnostic systems as part of its broader cardiovascular and neurological portfolio. Sophysa SA, headquartered in Montrouge, France, specializes in intracranial pressure monitoring solutions, including fiber-optic sensor systems that are widely deployed in neurocritical care. Raumedic AG, headquartered in Rehau, Germany, manufactures single-use medical devices such as catheters, tubing and sensors that intersect with intracranial pressure monitoring workflows.
B. Braun Melsungen AG, headquartered in Melsungen, Germany, supplies neurosurgical systems and ICP monitoring-related catheters and external drainage solutions used in intensive care units. Natus Medical Incorporated, headquartered in Pleasanton, California, United States, provides neurodiagnostic and monitoring solutions that include components compatible with intracranial pressure monitoring workflows. Stryker Corporation, headquartered in Kalamazoo, Michigan, United States, offers a neurosurgical portfolio that includes instrumentation and supportive devices used in ICP monitoring and critical care settings. DePuy Synthes, part of Johnson & Johnson, is headquartered in New Brunswick, New Jersey, United States, and markets neurosurgical systems including ICP monitoring hardware integrated within comprehensive brain injury care offerings.
Beyond these ten firms, the ICP monitoring devices market features a mix of established medical technology multinationals and specialized regional players that collectively drive adoption across hospitals, military medical facilities, and trauma centers. The leading groups maintain rigorous regulatory compliance and robust product pipelines that span intraparenchymal and intraventricular monitoring modalities, including fiber-optic sensors, microtransducers, and advanced EVD systems. Market dynamics are shaped by neurosurgical procedure volumes, critical care bed capacity, and the growing emphasis on neurocritical care pathways that integrate ICP data with cerebral perfusion metrics and multimodal monitoring. Geographic penetration remains strongest in North America and Europe, reflecting favorable reimbursement and well-developed hospital procurement, while Asia-Pacific shows sustained growth through increasing investments in tertiary care and academic centers. Strategic collaborations, acquisitions, and technology convergence—such as sensor miniaturization, wireless data transmission, and cloud-based data analysis—are likely to influence competitive positioning over the next five to ten years. The ten firms listed above collectively offer a broad spectrum of ICP monitoring solutions, from single-use catheters to integrated neurocritical care platforms, reinforcing their status as core constituents of contemporary neurosurgical practice and research. Their ongoing innovations shape patient outcomes worldwide.
Medtronic plc, headquartered in Dublin, Ireland, is a global leader in neuromonitoring and intracranial pressure monitoring devices, integrating ICP sensors with its broad portfolio of neurocritical care products. Integra LifeSciences Corp, headquartered in Plainsboro, New Jersey, United States, markets Codman ICP monitors and related neurocritical care hardware, reflecting its historical emphasis on neurosurgical instrumentation. Smiths Medical, based in London, United Kingdom, supplies ICP monitoring accessories and external drainage systems used in critical care settings, aligning with its broad portfolio of acute care devices. LivaNova PLC, headquartered in London, United Kingdom, operates in the neuromonitoring space with ICP sensors and associated neurodiagnostic systems as part of its broader cardiovascular and neurological portfolio. Sophysa SA, headquartered in Montrouge, France, specializes in intracranial pressure monitoring solutions, including fiber-optic sensor systems that are widely deployed in neurocritical care. Raumedic AG, headquartered in Rehau, Germany, manufactures single-use medical devices such as catheters, tubing and sensors that intersect with intracranial pressure monitoring workflows.
B. Braun Melsungen AG, headquartered in Melsungen, Germany, supplies neurosurgical systems and ICP monitoring-related catheters and external drainage solutions used in intensive care units. Natus Medical Incorporated, headquartered in Pleasanton, California, United States, provides neurodiagnostic and monitoring solutions that include components compatible with intracranial pressure monitoring workflows. Stryker Corporation, headquartered in Kalamazoo, Michigan, United States, offers a neurosurgical portfolio that includes instrumentation and supportive devices used in ICP monitoring and critical care settings. DePuy Synthes, part of Johnson & Johnson, is headquartered in New Brunswick, New Jersey, United States, and markets neurosurgical systems including ICP monitoring hardware integrated within comprehensive brain injury care offerings.
Beyond these ten firms, the ICP monitoring devices market features a mix of established medical technology multinationals and specialized regional players that collectively drive adoption across hospitals, military medical facilities, and trauma centers. The leading groups maintain rigorous regulatory compliance and robust product pipelines that span intraparenchymal and intraventricular monitoring modalities, including fiber-optic sensors, microtransducers, and advanced EVD systems. Market dynamics are shaped by neurosurgical procedure volumes, critical care bed capacity, and the growing emphasis on neurocritical care pathways that integrate ICP data with cerebral perfusion metrics and multimodal monitoring. Geographic penetration remains strongest in North America and Europe, reflecting favorable reimbursement and well-developed hospital procurement, while Asia-Pacific shows sustained growth through increasing investments in tertiary care and academic centers. Strategic collaborations, acquisitions, and technology convergence—such as sensor miniaturization, wireless data transmission, and cloud-based data analysis—are likely to influence competitive positioning over the next five to ten years. The ten firms listed above collectively offer a broad spectrum of ICP monitoring solutions, from single-use catheters to integrated neurocritical care platforms, reinforcing their status as core constituents of contemporary neurosurgical practice and research. Their ongoing innovations shape patient outcomes worldwide.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
